25 Jun 2009 13:00
25 June 2009
e-Therapeutics plc
Change of Adviser
The Board of e-Therapeutics plc (the 'Company') (AIM: ETX), the drug discovery and development company, is pleased to announce the appointment of Canaccord Adams Limited as the Nominated Adviser and Broker to the Company with immediate effect.
Enquiries:
e-Therapeutics plc O191 233 1317
John Cordiner, Finance Director
Canaccord Adams Limited
Nominated Adviser 0207 050 6500
Robert Finlay / Henry Fitzgerald-O'Connor